Login
CANNABINOIDS&PAIN  
    the state of the art, the state of the science  ●  2012
    official satellite symposium of the 14th World Congress on Pain
   August 25, 2012 ● Melia Milano Hotel, Milan, Italy 
Information ● Registration ● Agenda ● Call for Abstracts ● Sponsorship ● Venue
 
This symposium will explore the role of cannabinoids in pain medicine. This symposium will enable attendees to:
  • Understand recent developments in cannabinoid neuroscience
  • Be aware of Canadian cannabinoid research initiatives
  • Appreciate actual and potential clinical applications of cannabinoids
  • Reflect on attitudes toward use of cannabinoids in clinical practice
  • Recognize areas of need for cannabinoid research and education
The symposium will be divided into sessions providing updates focused on:
  • Cannabinoid research
  • Cannabinoid uses in clinical practice
  • Cannabinoids and the future
Registration is now open... and space is limited.

 

This event will be an update on the status of the therapeutic use of cannabinoids for pain building upon the success of the 2010 event.


   Supported by:
   Dissemination Events Grant from CIHR

   QPRN Support for Organization of Conferences

 
   Cortical Sponsors

     
   Thalamic Sponsors

  

 
Timely topics in pain research and treatment have been selected for presentation, but the information provided and opinions expressed have not involved any verification of the findings, conclusions, and opinions by the International Association for the Study of Pain (IASP)®. Thus, opinions expressed in this meeting do not necessarily reflect those of the Association or of the Officers and Councilors of IASP. No responsibility is assumed by the Association for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instruction, or ideas contained in the material herein. Because of the rapid advances in the medical sciences, the association recommends that independent verification of diagnoses and drug dosages should be made.